Ely Benaim

Insider Reports History

Location
Rockville, MD
Signature
/s/ Steven Robbins Attorney in Fact for Ely Benaim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ely Benaim:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Medical Officer Ordinary Shares 28,770 $363,941 $12.65 06 Jan 2023 Direct

Insider Reports Filed by Ely Benaim

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVCR NovoCure Ltd 06 Jan 2023 1 +$6,106 4 Chief Medical Officer 10 Jan 2023, 15:14
NVCR NovoCure Ltd 03 Aug 2022 2 -$439,328 4 Chief Medical Officer 04 Aug 2022, 16:32
NVCR NovoCure Ltd 02 Aug 2022 1 -$30,441 4 Chief Medical Officer 03 Aug 2022, 16:44
NVCR NovoCure Ltd 05 Jul 2022 1 +$13,115 4 Chief Medical Officer 07 Jul 2022, 17:47
NVCR NovoCure Ltd 10 May 2022 2 -$265,646 4 Chief Medical Officer 12 May 2022, 16:30
NVCR NovoCure Ltd 03 Mar 2022 5 +$2,724,949 4 Chief Medical Officer 07 Mar 2022, 17:18
NVCR NovoCure Ltd 06 Jan 2022 1 +$3,510 4 Chief Medical Officer 12 Jan 2022, 16:38
NVCR NovoCure Ltd 03 Aug 2021 1 -$69,651 4 Chief Medical Officer 04 Aug 2021, 16:59
NVCR NovoCure Ltd 30 Jul 2021 4 -$129,321 4 Chief Medical Officer 03 Aug 2021, 17:29
NVCR NovoCure Ltd 06 Jul 2021 1 +$12,341 4 Chief Medical Officer 08 Jul 2021, 17:32
NVCR NovoCure Ltd 27 May 2021 3 -$279,423 4 Chief Medical Officer 28 May 2021, 16:36
NVCR NovoCure Ltd 12 May 2021 1 -$350,673 4 Chief Medical Officer 14 May 2021, 16:07
NVCR NovoCure Ltd 10 May 2021 4 -$667,878 4 Chief Medical Officer 12 May 2021, 16:15